Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 5.1B | 2.3B | 3.2B |
Cost of revenue | 1.9B | 3.4B | 1.7B | 2.4B |
Gross profit | 674.2M | 1.7B | 656.9M | 833.6M |
Operating expense | ||||
Research & development | 390.3M | 309.4M | 358.0M | 261.6M |
Selling general and admin | 229.2M | -457.5M | 617.2M | -90.2M |
Other operating expenses | 10.9M | 23.8M | 8.6M | 14.6M |
Operating income | 113.7M | 1.2B | 154.2M | 407.7M |
Non operating interest income | ||||
Income | 22.6M | 20.5M | 20.6M | 30.6M |
Expense | 4.2M | 8.3M | 14.8M | 17.9M |
Other income expense | — | — | — | — |
Pretax income | 232.3M | 1.2B | 314.0M | 536.5M |
Tax provision | 63.0M | 42.5M | 76.3M | 100.6M |
Net income | 169.4M | 1.2B | 237.7M | 435.9M |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 1.5B | — | — | — |
Diluted average shares | 1.5B | — | — | — |
EBITDA | 259.6M | 1.4B | 357.9M | 594.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | 17.1M | -46.8M | -31.3M | -15.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |